搜索临床试验以:Mesenchymal-epithelial transition factor (MET) inhibitor
总计125047个结果
-
Chungbuk National University HospitalMerck KGaA, Darmstadt, Germany招聘中
-
Symphogen A/S完全的
-
Fujian Cosunter Pharmaceutical Co. Ltd未知实体瘤 | C-Met Mutation-Related Tumors中国
-
University of OsloThe Research Council of Norway; University of Oxford完全的
-
Elcelyx Therapeutics, Inc.完全的
-
University of Applied Sciences Upper AustriaKrankenhaus der Barmherzigen Schwestern Ried未知
-
SCRI Development Innovations, LLCNovartis完全的
-
Deciphera Pharmaceuticals LLC终止
-
Brown UniversityNational Institute on Drug Abuse (NIDA)主动,不招人
-
Haihe Biopharma Co., Ltd.招聘中
-
Louis Turcanu Emergency Hospital for ChildrenUniversity of Medicine and Pharmacy "Victor Babes" Timisoara完全的肥胖,代谢良性
-
Alexandru Florin RogobeteUniversity of Medicine and Pharmacy "Victor Babes" Timisoara完全的
-
National Jewish HealthNational Heart, Lung, and Blood Institute (NHLBI); The Miriam Hospital; National Center for Research...完全的
-
University of ConnecticutNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.招聘中非小细胞肺癌 | BRAF V600突变 | MET扩增 | MET 外显子 14 跳跃突变 | RET驱动突变 | Erb-B2 受体酪氨酸激酶外显子 20 突变中国
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)完全的
-
Elcelyx Therapeutics, Inc.完全的
-
Pfizer完全的系统性间变性大细胞淋巴瘤 | 非小细胞肺癌 ALK 阳性 | 非小细胞肺癌 c-Met 依赖 | 非小细胞肺癌 ROS 标志物阳性 | 除白血病外的晚期恶性肿瘤美国, 大韩民国, 澳大利亚, 日本